| |
| |
|
| Insider
Information: |
Ryan Jason |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
188,356 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$4,021,401 |
|
|
| Total
Shares |
188,356 |
|
|
| Total
Value |
$4,021,401 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 1,226.2%
|
376.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foundation Medicine, Inc. |
FMI |
Chief Financial Officer |
2018-07-31 |
0 |
2014-04-16 |
0 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2024-01-11 |
0 |
2024-01-11 |
188,356 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,836 |
12,836 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,278 |
17,114 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
247,525 |
263,358 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
129 |
5,876 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
67,780 |
73,614 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2024-01-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
73,614 |
0 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-04-16 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-05-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-05 |
4 |
OE |
$0.08 |
$800 |
D/D |
10,000 |
5,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-05 |
4/A |
OE |
$0.08 |
$382 |
D/D |
4,773 |
4,773 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-09 |
4 |
OE |
$0.08 |
$94 |
D/D |
1,180 |
1,180 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-16 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-06-26 |
4 |
OE |
$0.08 |
$94 |
D/D |
1,180 |
1,180 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-07-15 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-08-15 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-09-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-10-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-10-27 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,360 |
2,360 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-11-17 |
4 |
OE |
$0.08 |
$283 |
D/D |
3,541 |
3,541 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2014-12-15 |
4 |
OE |
$0.08 |
$189 |
D/D |
2,361 |
2,361 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Senior Vice President, Finance |
• – – |
2015-02-27 |
4 |
OE |
$0.08 |
$84,430 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-12-05 |
4 |
OE |
$0.08 |
$133,302 |
D/D |
21,726 |
71,289 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-12-31 |
4 |
S |
$0.26 |
$19,310 |
D/D |
(73,732) |
189,626 |
0 |
% |
|
| FMI |
Foundation Medicine, Inc. |
Chief Financial Officer |
• – – |
2017-03-16 |
4 |
OE |
$0.84 |
$41,210 |
D/D |
12,500 |
65,480 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Executive Chairman |
• • – |
2022-10-17 |
4 |
S |
$0.86 |
$1,101 |
D/D |
(1,281) |
15,833 |
0 |
% |
|
78 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
